Fertility Company Hit With Embryo Genetic Testing False-Ad Suit

Reproductive Genetic Innovations Inc., a self-described leader in assisted reproductive technology, misleads patients undergoing in-vitro fertilization procedures about the accuracy of genetic testing meant to screen embryos for chromosomal abnormalities, a proposed consumer class action alleged Friday.

“Patients with unexplained recurrent implantation failure are precisely the type of vulnerable and unsuspecting consumers” that RGI is marketing to, the complaint filed in the US District Court for the Northern District of Illinois said.

The company sells preimplantation genetic testing for aneuploidy—the presence of an abnormal number of chromosomes—marketing it as a proven, accurate, and reliable method for decreasing the chance ...